Affiliation:
1. University of Medicine of Göttingen (UMG) Göttingen Germany
2. HAN University of Applied Sciences Nijmegen The Netherlands
3. Federal University of Ceará (UFC) Fortaleza Brazil
Abstract
AbstractNeurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases.